These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9860788)

  • 1. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation.
    Pandozi C; Bianconi L; Villani M; Gentilucci G; Castro A; Altamura G; Jesi AP; Lamberti F; Ammirati F; Santini M
    Circulation; 1998 Dec 22-29; 98(25):2860-5. PubMed ID: 9860788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relations between monophasic action potential duration and refractoriness after cardioversion of persistent atrial fibrillation: results in wash-out and amiodarone-treated patients.
    Pandozi C; Gentilucci G; Calò L; Castro A; Lamberti F; Loricchio ML; Santini L; Magris B; Bulava A; Peichl P; Santini M
    Ital Heart J; 2003 Apr; 4(4):257-63. PubMed ID: 12784779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation.
    Pandozi C; Bianconi L; Calò L; Castro A; Lamberti F; Scianaro MC; Gentilucci G; Santini M
    J Am Coll Cardiol; 2000 Dec; 36(7):2234-41. PubMed ID: 11127466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of amiodarone on dispersion of atrial refractoriness and cycle length in patients with atrial fibrillation.
    Fynn SP; Todd DM; Hobbs WJ; Armstrong KL; Fitzpatrick AP; Garratt CJ
    J Cardiovasc Electrophysiol; 2003 May; 14(5):485-91. PubMed ID: 12776865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation.
    Raitt MH; Kusumoto W; Giraud G; McAnulty JH
    J Cardiovasc Electrophysiol; 2004 May; 15(5):507-12. PubMed ID: 15149416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.
    Galperín J; Elizari MV; Chiale PA; Molina RT; Ledesma R; Scapín AO; Blanco MV; Bonato R; Lago M;
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):179-86. PubMed ID: 14506542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study.
    Manios EG; Mavrakis HE; Kanoupakis EM; Kallergis EM; Dermitzaki DN; Kambouraki DC; Vardas PE
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):31-9. PubMed ID: 12843685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man.
    Yu WC; Lee SH; Tai CT; Tsai CF; Hsieh MH; Chen CC; Ding YA; Chang MS; Chen SA
    Cardiovasc Res; 1999 May; 42(2):470-6. PubMed ID: 10533582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion.
    Boriani G; Diemberger I; Biffi M; Camanini C; Valzania C; Corazza I; Martignani C; Zannoli R; Branzi A
    Int J Cardiol; 2005 Jun; 101(3):355-61. PubMed ID: 15907401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early reinitiation of atrial fibrillation following external electrical cardioversion in amiodarone-treated patients.
    Reithmann C; Dorwarth U; Gerth A; Remp T; Steinbeck G; Hoffmann E
    J Interv Card Electrophysiol; 2001 Sep; 5(3):285-92. PubMed ID: 11500583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
    Wirth KJ; Knobloch K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):166-74. PubMed ID: 11218069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of IKr blocker nifekalant on atrial action potential duration after successful internal cardioversion of chronic atrial fibrillation.
    Kofune T; Watanabe I; Okubo K; Okumura Y; Masaki R; Shindo A; Saito S
    Pacing Clin Electrophysiol; 2005 May; 28(5):391-6. PubMed ID: 15869670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate-dependent electrophysiologic effects of the class III antiarrhythmic drugs nifekalant, amiodarone, and ibutilide on the atrium in patients with persistent atrial fibrillation.
    Sonoda K; Watanabe I; Ohkubo K; Okumura Y; Kofune M; Sasaki N; Kogawa R; Mano H; Nakai T; Hirayama A
    Int Heart J; 2013; 54(5):279-84. PubMed ID: 24097216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation.
    Tse HF; Lau CP
    J Am Coll Cardiol; 2002 Dec; 40(12):2150-5. PubMed ID: 12505228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal changes in atrial refractoriness following DC cardioversion of persistent atrial fibrillation in man.
    Spurrell P; Kamalvand K; Higson M; Sulke N
    Europace; 2004 May; 6(3):229-35. PubMed ID: 15121076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant prolongation of atrial monophasic action potential duration: short-term reverse electrophysiological changes after internal cardioversion of atrial fibrillation.
    Korte T; Niehaus M; Borchert G; Tebbenjohanns J
    Cardiovasc Res; 2002 Mar; 53(4):944-51. PubMed ID: 11922904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone.
    Van Noord T; Van Gelder IC; Schoonderwoerd BA; Crijns HJ
    Am J Cardiol; 2000 Dec; 86(12):1384-5, A5. PubMed ID: 11113420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.